A possible link between insulin glargine and malignancy : the facts: comment from Prof François Bonnici

Cardiovasc J Afr. 2009 Jul-Aug;20(4):218; discussion 218-9.
No abstract available

Publication types

  • Editorial

MeSH terms

  • Humans
  • Hypoglycemic Agents / adverse effects*
  • Insulin / adverse effects
  • Insulin / analogs & derivatives*
  • Insulin Glargine
  • Insulin, Long-Acting
  • Neoplasms / chemically induced*
  • Risk Assessment

Substances

  • Hypoglycemic Agents
  • Insulin
  • Insulin, Long-Acting
  • Insulin Glargine